Experimental mRNA Nasal Drops Boost Memory and Prevent Cognitive Decline in Mice
University of Sydney researchers developed experimental nasal drops utilizing mRNA technology that successfully enhanced memory in aged mice and protected an Alzheimer's disease mouse model from cognitive decline.
🔬ResearchPhoto: Medical Xpress
Key points
- Experimental nasal drops use mRNA technology to boost brain-derived neurotrophic factor.
- The noninvasive treatment successfully bypassed the blood-brain barrier in mice.
- Memory improved in aged mice and was protected in an Alzheimer's model without clearing amyloid plaques.
Scientists at the University of Sydney have created an experimental nasal spray that improves learning and memory in older mice while preventing memory deterioration in a mouse model of Alzheimer's disease. Led by Professor Greg Neely at the Charles Perkins Center, the study utilized messenger RNA technology packaged within lipid nanoparticles—a delivery system similar to that used in COVID-19 vaccines. Published in Advanced Science, the study was inspired by the science fiction story "Flowers for Algernon."
The nasal treatment delivers mRNA instructions designed to prompt the nasal passages to produce brain-derived neurotrophic factor (BDNF), a natural protein vital for neuron survival, plasticity, and memory formation. Because BDNF levels typically decline with age and in neurodegenerative conditions, researchers administered the treatment twice weekly to aged mice and a rapid-onset Alzheimer's model. Treated aged mice performed comparably to young mice in standard behavioral tests, while the Alzheimer's model mice were protected against expected severe cognitive decline.
Notably, the therapy preserved brain function without clearing amyloid plaques, which are protein clumps classically associated with Alzheimer's. This suggests that raising BDNF levels may help support neuron health independently of plaque clearance. However, readers should note that these findings are currently limited to preclinical animal models, and researchers emphasize that human clinical trials are required to test safety and efficacy. Always consult a qualified healthcare provider for personal medical decisions.
What to know:
- Researchers developed noninvasive nasal drops using mRNA technology to deliver brain-supporting proteins directly to the central nervous system.
- The treatment restored cognitive function in aged mice and prevented memory loss in an Alzheimer's mouse model without reducing amyloid plaques.
- The approach successfully bypassed the blood-brain barrier in preclinical tests, though human clinical trials are still needed.
Source Medical Xpress — medicalxpress.com/news/2026-11-algernon-experimental-nose-memory-mice.h… ↗
Read next
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🧠Mind & Mental HealthThe Role of Daily Mobility Training in Managing Sedentary Tension
A two-week personal trial suggests that incorporating short, daily mobility exercises may help alleviate stiffness associated with sedentary desk work. Experts note that …
🧠Mind & Mental HealthNew Theoretical Framework Explores Memory Formation and Dementia
Researchers have proposed a new model suggesting the brain's limbic system functions similarly to generative AI, potentially offering a new way to understand and classify…